OmniLenz is a bespoke bandage contact lens that allows for easy application of Omnigen, Tereo® processed amniotic membrane, to the ocular surface in an ambulatory setting, without the need for surgery or sutures. OmniLenz, developed in conjunction with Menicon Ltd (https://www.menicon.co.uk), provides health care professionals with capability of accessing the healing benefits of amniotic membrane in a routine clinic setting using a simple 4 – 6 minute procedure.
NuVision are pleased to announce the launch of our digital OmniLenz application training guide, which demonstrates the ease of OmniLenz use:
Dr. Andrew Hopkinson, the Founder and Chief Scientific Officer of NuVision stated: ‘We developed OmniLenz to make the benefits of amnion-healing accessible in mainstream environment. This presents new opportunities to treat greater numbers of patients with milder and superficial ocular disease1 in a range of clinical settings.
With the increased pressures placed on the NHS by the COVID-19 pandemic, and the subsequent need to treat patients fast and effectively, away from a theatre setting – OmniLenz application of Omnigen delivers the ability to treat patients in an out-patient setting. NuVision believes OmniLenz application of Omnigen provides a solution that can aid the recovery of service providers to ensure patients receive the best care”
For additional on information on OmniLenz, please visit: https://www.nu-vision.co.uk/omnilenz/ or contact NuVision at info@nu-vision.co.uk
References:
1. Walkden, A., Amniotic Membrane Transplantation in Ophthalmology: An Updated Perspective. Clin Ophthalmol 2020, 14, 2057-2072.
